# Combination of Hypofractionated Proton Therapy With Immunotherapy

> **NCT03764787** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Peking University First Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Proton Therapy
- Immunotherapy

## Interventions

- **COMBINATION_PRODUCT:** Radiation+PD-1 Ab

## Key facts

- **NCT ID:** NCT03764787
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2021-01-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03764787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03764787, "Combination of Hypofractionated Proton Therapy With Immunotherapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03764787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*